Refine by
In Vivo Study Equipment Supplied In Europe
13 equipment items found
Manufactured by:3D Medical based inMarolles-en-Brie, FRANCE
In-vivo study of porous structures made in titanium via SLM allows to observe the excellent osteointegration of this type of ...
Manufactured by:Futura Medical based inGuildford, UNITED KINGDOM
TIB200 is a topical 10% ibuprofen gel for pain relief that utilises Futura's DermaSys® technology. DermaSys® enables ibuprofen to be delivered rapidly and efficiently through the skin. Local application and rapid, efficient absorption translate into a fast onset of action, and the potential for twice-daily ...
Manufactured by:Histocell based inDerio, SPAIN
The HC016 platform is a treatment of acute lung injury, based on mesenchymal stem cells derived from adipose tissue (ASC), improved with proprietary Histocell ...
Manufactured by:Nobel Biocare based inKloten, SWITZERLAND
A membrane with outstanding handling1,2 that facilitates bone gain. A resorbable collagen membrane for guided bone regeneration and guided tissue regeneration ...
Manufactured by:InStar Technologies a.s. based inLiberec, CZECH REPUBLIC
With our OTF InStrip: technology we are able to work with a wide range of physiologically active substances, the delivery of which we can modify according to the nature of substance and requirements of the partner. The technology gives the advantage to produce products for both human and veterinary ...
Manufactured by:InStar Technologies a.s. based inLiberec, CZECH REPUBLIC
Cebedix & Cebidix-h are an Oral Thin Films using our InStripTM technology with CBD (Canabidiol). InStrip technology allows you to use the full potential of the substances contained in Cebedix, in this case CBD. You will achieve the desired effect from a much smaller dose. And a smaller dose means a smaller toll on the organism. The first effects of Cebedix in the form of a thin, ...
Manufactured by:Selenium Medical based inLa Rochelle, FRANCE
StarSurf® is a surface treatment process enabling to create a rough structure on the surface of implants made of titanium and titanium alloys thus improving their biological performance of osseointegration. Implants surface finishing plays a crucial role in the success of an implantation surgery. As a matter of fact, the first contact between the implant and the patient’s body is a key ...
Manufactured by:Alzinova AB based inMölndal, SWEDEN
ALZ-101 is a vaccine that stimulates the production of antibodies against the toxic Aβ oligomers. A first-in-human study in patients with early Alzheimer’s disease was initiated during third quarter of ...
Manufactured by:Teknimed based inL’union, FRANCE
Thanks to its composition, NANOGEL® is a synthetic bone substitute similar to mineral phase of bone. This product is an absorbable bone void filler which induces a rapid bone ingrowth. NANOGEL® offers to surgeon various possibilities of use : percutaneous surgery to fill closed bone defects or open ...
Manufactured by:Novostia SA based inEpalinges, SWITZERLAND
Your heart is the most important muscular organ in your body. It is a two-sided pump that beats about 100,000 times a day (more than 2 billion times in an average lifetime) to keep your blood circulation going. The right side of the heart pumps blood through the lungs where it picks up oxygen. The left side of the heart receives the blood containing oxygen and pumps the blood to the rest of your ...
Manufactured by:Sartorius AG based inGoettingen, GERMANY
Innovation is at the heart of everything we do. Our proprietary drug delivery technology platform, Veltis®, uses engineered recombinant albumin to enhance albumin’s intrinsic characteristics for optimal therapeutic performance of your ...
Manufactured by:Inovotion Sas based inLa Tronche, FRANCE
INOVOTION has developed a unique, highly sensitive and reproducible assay. It is applicable to all preclinical oncology and immuno-oncology drug discovery programs, and monitors the growth and metastatic dissemination of human tumor ...
by:Pure Biologics SA based inWroclaw, POLAND
Colorectal cancer (CRC) is the second-most common cancer diagnosed in women and third-most in men. Based upon five-year survival rates, chances of becoming cured remain to be approximately 65%. Therapies targeting immunological checkpoints, or more specifically their inhibition, promise effective treatment options for patients with metastatic forms of this disease. In the PB001 project, Pure ...